510(k) K250420
K250420 is an FDA 510(k) premarket notification submitted by Helios Biomedical, Inc. for the device "Helios Dura Regeneration Matrix". The FDA issued a decision of Substantially Equivalent on May 14, 2025. The device falls under product code GXQ (Dura Substitute), a Class II device regulated under 21 CFR 882.5910. Helios Biomedical, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 14, 2025
- Date Received
- February 13, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dura Substitute
- Device Class
- Class II
- Regulation Number
- 882.5910
- Review Panel
- NE
- Submission Type